NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
58.78
+1.57 (+2.74%)
At close: 4:00PM EDT

58.78 0.00 (0.00%)
After hours: 4:07PM EDT

Stock chart is not supported by your current browser
Previous Close57.21
Open56.93
Bid58.80 x 900
Ask58.83 x 800
Day's Range56.77 - 59.10
52 Week Range43.51 - 72.41
Volume587,356
Avg. Volume707,501
Market Cap3.048B
Beta (3Y Monthly)1.38
PE Ratio (TTM)244.92
EPS (TTM)0.24
Earnings DateMay 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est58.19
Trade prices are not sourced from all markets
  • NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks9 hours ago

    NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth

    NuVasive (NUVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK
    PR Newswire2 days ago

    Clinical Study Demonstrates NuVasive Cohere® Porous PEEK™ Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK

    SAN DIEGO, April 22, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study "Early Clinical Outcomes Comparing Porous PEEK, Smooth PEEK, and Structural Allograft Interbody Devices for Anterior Cervical Discectomy and Fusion," published online in the Journal of Spine & Neurosurgery, which concludes that the NuVasive proprietary Cohere® Porous polyetheretherketone (PEEK) implant demonstrates a clear benefit in promoting improved early outcomes over structural allograft and smooth PEEK in anterior cervical discectomy and fusion (ACDF) procedures. In the study, 167 patients presenting with degenerative cervical disc disease underwent ACDF using Cohere Porous PEEK™, structural allograft or smooth PEEK in the interbody space.

  • NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results
    PR Newswire9 days ago

    NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results

    SAN DIEGO, April 15, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its first quarter 2019 earnings results on Wednesday, May 1, 2019 after the close of the market. NuVasive will hold a conference call on Wednesday, May 1, 2019, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the first quarter 2019. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers.

  • Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019
    PR Newswire14 days ago

    Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360™ System At AANS 2019

    Integrated Procedural System Advances Approach to Minimally Invasive Surgery SAN DIEGO , April 11, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused ...

  • Markit15 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVAView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is moderate for NUVA with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding NUVA are favorable with net inflows of $72.43 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards
    PR Newswire19 days ago

    NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards

    SAN DIEGO, April 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform was voted a gold winner in the advanced surgical instruments category at the 2019 Edison Awards™ held in New York City on April 4. The LessRay platform is built on a proprietary algorithm that captures and enhances low-dose, low-quality images to produce images with similar diagnostic capabilities as conventional full-dose images. This technology has the ability to reduce radiation emissions to the operating room (OR) staff and patient by 75 percent compared to standard fluoroscopy.1 Also included in this multi-functional platform are tools designed to increase OR efficiency through streamlined surgical workflow and redefined anatomical visualization.

  • NuVasive (NUVA) Completes First COHERE XLIF Case in U.S.
    Zacks22 days ago

    NuVasive (NUVA) Completes First COHERE XLIF Case in U.S.

    NuVasive's (NUVA) Advanced Materials Science implant portfolio will be fortified by the incorporation of the Porous PEEK technology into its implants for lateral single-position surgery.

  • NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases
    PR Newswire23 days ago

    NuVasive Proprietary Porous PEEK™ Technology Used In First XLIF® Spine Surgery Cases

    SAN DIEGO, April 1, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the first-case uses of Cohere® XLIF, the first-of-its-kind lateral Porous PEEK™ implant for XLIF® and lateral single-position surgery. The NuVasive Advanced Materials Science™ implant portfolio will remain on the forefront of innovation by incorporating Porous PEEK technology into its implants for lateral single-position surgery and beyond.

  • NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound?
    Zackslast month

    NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound?

    NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Options Bears Jump on Battered NuVasive Stock
    Schaeffer's Investment Researchlast month

    Options Bears Jump on Battered NuVasive Stock

    NUVA stock is lower on would-be suitor Smith & Nephew plans to buy Osiris Therapeutics

  • NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019
    PR Newswire2 months ago

    NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019

    SAN DIEGO, March 6, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its participation in and sponsorship of Spine Summit 2019 – 35th Annual Meeting of the Section on Disorders of the Spine and Peripheral Nerves, held March 14–17, 2019 at the Fountainebleau Miami Beach. NuVasive will facilitate surgeon education experiences at the summit through participation in a surgery lab featuring the latest advances in lateral single-position surgery (LSPS) and hosting a workshop focused on Anterior Lumbar Interbody Fusion (ALIF) and Transforaminal Lumbar Interbody Fusion (TLIF) procedural solutions.

  • Why NuVasive Stock Rose 18% in February
    Motley Fool2 months ago

    Why NuVasive Stock Rose 18% in February

    The spinal surgery specialist gained market share last year and expects to repeat that success in 2019.

  • GlobeNewswire2 months ago

    Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference
    PR Newswire2 months ago

    NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference

    SAN DIEGO, March 5, 2019 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive management will present at the Cowen and Company 39th Annual Health Care Conference at The Boston Marriott Copley Place in Boston on Tuesday, March 12, 2019, at 9:20 a.m. ET / 6:20 a.m. PT. A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT

    Q4 2018 NuVasive Inc Earnings Call

  • NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall
    Zacks2 months ago

    NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall

    NuVasive (NUVA) reports growth in revenues across all key operating segments in the fourth quarter of 2018.

  • NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference
    PR Newswire2 months ago

    NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference

    NuVasive, Inc. (NUVA) is the leader in spine technology innovation, focused on transforming spine surgery and beyond with minimally disruptive, procedurally integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.

  • NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript
    Motley Fool2 months ago

    NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript

    NUVA earnings call for the period ending December 31, 2018.

  • NuVasive Overcomes Industry Headwinds to Finish 2018 Strong
    Motley Fool2 months ago

    NuVasive Overcomes Industry Headwinds to Finish 2018 Strong

    Some revenue weakness didn't hold back the spinal surgery specialist's bottom-line growth.

  • NuVasive (NUVA) Q4 Earnings and Revenues Top Estimates
    Zacks2 months ago

    NuVasive (NUVA) Q4 Earnings and Revenues Top Estimates

    NuVasive (NUVA) delivered earnings and revenue surprises of 9.52% and 0.01%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    NuVasive: 4Q Earnings Snapshot

    On a per-share basis, the San Diego-based company said it had net income of 23 cents. Earnings, adjusted for amortization costs and non-recurring costs, came to 69 cents per share. The results surpassed ...

  • NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results
    PR Newswire2 months ago

    NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results

    Company provides 2019 financial performance guidance SAN DIEGO , Feb. 20, 2019 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery ...

  • ACCESSWIRE2 months ago

    NuVasive, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 20, 2019 / NuVasive, Inc. (NASDAQ: NUVA ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on February 20, 2019 at 4:30 PM ...